Caicun Zhou, PHD
Shanghai Pulmonary Hospital, Shanghai, China · Shanghai East Hospital · Shanghai Pulmonary Hospital, Tongji University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Caicun Zhou, PHD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:27 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06758557 · A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid TumorHuabo Biopharm Co., Ltd. · recruiting · Advanced NSCLC, Advanced Endometrial Cancer · principal investigator
- Ph1NCT06612840 · A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Non-small Cell Lung Cancer, Solid Tumor · principal investigator
- Ph2NCT06437509 · A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung CancerSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Extensive-stage Small-cell Lung Cancer · principal investigator
- Ph1/Ph2NCT05949619 · A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Non-small Cell Lung Cancer · principal investigator
- Ph1/Ph2NCT05949606 · A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung CancerSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT05880706 · A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT03904823 · A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLCJiangsu HengRui Medicine Co., Ltd. · unknown · EGFR-mutant Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT03886441 · Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone PropionateTongji University · unknown · Locally Advanced Non Small Cell Lung Cancer · principal investigator
- Ph1NCT03852823 · Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced TumoursCSPC ZhongQi Pharmaceutical Technology Co., Ltd. · unknown · Advanced Solid Tumours, Cervical Cancer, Malignant Mesothelioma · principal investigator
- Ph3NCT03358875 · Comparison of Efficacy and Safety of Tislelizumab (BGB-A317) Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With Non-Small Cell Lung Cancer (NSCLC)BeiGene · completed · Non-small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.